Showing results (141-150 of 174) with videos related to

Sort By:
Pageof 18
Journal of Immunotherapy (Hagerstown, Md. : 1997)|September 9, 2014
TCR+CD4-CD8- T cells in antigen-specific MHC class I-restricted T-cell responses after allogeneic hematopoietic stem cell transplantationRaija K Ahmed, Thomas Poiret, Aditya Ambati, et al.
British Journal of Haematology|September 18, 2025
Can we move beyond myeloablative conditioning (MAC)? A comparison of MAC versus reduced intensity conditioning (RIC) in patients aged younger than 65 years undergoing allogeneic haematopoietic cell transplantation using ATG-PTCy-CSA for GVHD prophylaxisRuah Alyamany, Ahmed Alnughmush, Mats Remberger, et al.
Haematologica|February 29, 2012
Evaluation of prognostic factors among patients with chronic graft-versus-host diseaseJose A Pérez-Simón, Gabriel Afram, Rodrigo Martino, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|June 16, 2022
Relationship between certain HLA alleles and the risk of cytomegalovirus reactivation following allogeneic hematopoietic stem cell transplantationShruti Prem, Mats Remberger, Ahmad Alotaibi, et al.
European Journal of Haematology|July 18, 2023
Influence of conditioning regimen intensity on outcomes post-allogeneic hematopoietic cell transplantation for acute myeloid leukemia in complete morphological remissionTommy Alfaro Moya, Jonas Mattsson, Mats Remberger, et al.
Frontiers in Immunology|July 27, 2017
Safety and Side Effects of Using Placenta-Derived Decidual Stromal Cells for Graft-versus-Host Disease and Hemorrhagic CystitisArjang Baygan, Wictor Aronsson-Kurttila, Gianluca Moretti, et al.
European Journal of Haematology|December 14, 2021
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donorsIgor Novitzky-Basso, Mats Remberger, Carol Chen, et al.
Leukemia & Lymphoma|May 14, 2026
CMV reactivation post allogeneic stem cell transplantation decreases relapse risk and survival, and increases NRM - a single center analysisVered Stavi, Carol Chen, Igor Novitzky-Basso, et al.
Lancet (London, England)|May 13, 2008
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II studyKatarina Le Blanc, Francesco Frassoni, Lynne Ball, et al.
Transplantation and Cellular Therapy|July 15, 2025
Effect of Anti-Thymocyte Globulin and Post-Transplant Cyclophosphamide on Graft-Versus-Host Disease Outcomes in Female Donor-to-Male Recipient Matched Unrelated Donor Allogeneic Stem Cell Transplantation for Acute LeukemiaNihar Desai, Sergio Rodriguez-Rodriguez, Mats Remberger, et al.
Pageof 18